Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results have been mostly positive.